Big Move For Belite Bio Inc
Tue, May 03, 2022 at 05:35 PM
Belite Bio Inc (BLTE:NASDAQ) soared at $11.6, representing a gain of 30.8%. On Mon, May 02, 2022, BLTE:NASDAQ hit a New 2-Week Intraday High of $11.71. The stock appeared on our News Catalysts scanner on Tue, May 03, 2022 at 02:34 PM in the 'BIOTECH' category.
About Belite Bio Inc (BLTE:NASDAQ)
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic...
Top 10 Gainers:
- Blue Water Vaccines Inc. (BWV:NASDAQ), 93.11%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 59.13%
- Ostin Technology Group Co. Ltd. (OST:NASDAQ), 57.28%
- Kaleido Biosciences, Inc. (KLDO:NASDAQ), 54%
- Titan Medical Inc. (TMDI:NASDAQ), 32.7%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 31.58%
- Belite Bio Inc (BLTE:NASDAQ), 30.78%
- Sesen Bio, Inc. (SESN:NASDAQ), 29.97%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 28.23%
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 25.24%